Fisher Investments: $3B Strategic Partnership with Advent, ADIAby Mark Eisenberg 16.06.2024Advent and ADIA invest $2.5-$3B, valuing Fisher Investments at $12.75B. Founder Ken Fisher sells holdings. New board member: Advent's Mussafer.
AI in Finance: Major Shift Equals Major Opportunityby Terry Bingman 16.06.2024Generative AI is revolutionizing finance by automating tasks, answering tax queries swiftly, creating new roles, but basics in finance remain ...
First Bitcoin ETF to List on Australia’s Main Bourseby John Darbie 16.06.2024Hong Kong's Bitcoin & Ether ETFs see limited traction, unlike US. Australia's Bitcoin ETFs had mixed results but optimism grows ...
Warburg in Talks with QIA for Shriram Housing Finance Dealby Mark Eisenberg 16.06.2024Warburg Pincus & QIA may co-invest in SHFL via Mango Crest; Valiant to divest equity. JM Financial, Barclays, Avendus advised.
Experts Predict Dogecoin ETF as Meme Coins Gain Tractionby John Darbie 16.06.2024Dogecoin could potentially secure an ETF by the market cycle's end, BitMEX's Hayes and Pal agree. DOGE trades at $0.13. ...
New Investments in Child Care Crucial for Military Familiesby Mark Eisenberg 16.06.2024Local military families face a child care crisis, spending 26% of income. With only 750 slots on base, they rely ...
Ultrium AI: Revolutionizing Mobility Tech in Detroitby Lilu Anderson 15.06.2024Ultrium leverages real-time data to address mobility issues, promising new innovations. “We aim to understand and solve problems,” says CEO ...
BlackRock CIO Bets Big on DTX Over Ethereum & Polygonby John Darbie 15.06.2024DTX Exchange's utility token, DTX, is set to outperform Ethereum and Polygon due to its unique ecosystem advantages, making it ...
Drones Patrol Shores: A New Age in Crime-Fighting Technologyby Lilu Anderson 15.06.2024The department's new drone fleet, patrolling bays, beaches, and boardwalks, proves effective; hopes to train more officers as certified pilots.
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.